Evidence map›Paper›PMID 24819392›Full record

ArticlePloS one2014

The adult livers of immunodeficient mice support human hematopoiesis: evidence for a hepatic mast cell population that develops early in human ontogeny.

Marcus O Muench, Ashley I Beyer, Marina E Fomin, Rahul Thakker, Usha S Mulvaney, Masato Nakamura, Hiroshi Suemizu, Alicia Bárcena

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Fetal liver CD34Stem cell research & therapy · 2024
    Article
  2. Article
  3. A Monocytic Barrier to the Humanization of Immunodeficient Mice.Current stem cell research & therapy · 2024
    Review
  4. Article
  5. Preclinical PET and MR Evaluation ofNanomaterials (Basel, Switzerland) · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Marcus O MuenchBlood Systems Research Institute, San Francisco, California, United States of America; Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America; Liver Center, University of California San Francisco, San Francisco, California, United States of America.
Ashley I BeyerBlood Systems Research Institute, San Francisco, California, United States of America.
Marina E FominBlood Systems Research Institute, San Francisco, California, United States of America; Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America.
Rahul ThakkerBlood Systems Research Institute, San Francisco, California, United States of America.
Usha S MulvaneyBlood Systems Research Institute, San Francisco, California, United States of America.
Masato NakamuraBiomedical Research Department, Central Institute for Experimental Animals, Kawasaki, Japan.
Hiroshi SuemizuBiomedical Research Department, Central Institute for Experimental Animals, Kawasaki, Japan.
Alicia BárcenaBlood Systems Research Institute, San Francisco, California, United States of America; Department of Obstetrics, Gynecology and Reproductive Sciences, Institute for Regeneration Medicine, University of California San Francisco, San Francisco, California, United States of America.
Blood Systems Research Institute · USCentral Institute for Experimental Animals · JPCalifornia Institute for Regenerative Medicine · US

Funding

UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JACQUELYN J. MAHER · 1986 to 2026
$30.7M
Reprogramming iPS Cells with Exogenous and Endogenous Transcription Factor GenesP01DK088760 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRUENERT, DIETER C · 2011 to 2015
$6.5M
The human placenta as a novel source of hematopoietic stem cellsR21HD055328 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BARCENA, ALICIA LIZCANO · 2008 to 2009
$433k
NICHD NIH HHS R21 HD055328NIDDK NIH HHS P01 DK088760NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

The liver plays a vital role in hematopoiesis during mammalian prenatal development but its hematopoietic output declines during the perinatal period. Nonetheless, hepatic hematopoiesis is believed to persist into adulthood. We sought to model human adult-liver hematopoiesis by transplantation of fetal and neonatal hematopoietic stem cells (HSCs) into adult immunodeficient mice. Livers were found to be engrafted with human cells consisting primarily of monocytes and B-cells with lesser contributions by erythrocytes, T-cells, NK-cells and mast-cells. A resident population of CD117(++)CD203c(+) mast cells was also documented in human midgestation liver, indicating that these cells comprise part of the liver's resident immune cell repertoire throughout human ontogeny. The murine liver was shown to support human multilineage hematopoiesis up to 321 days after transplant. Evidence of murine hepatic hematopoiesis was also found in common mouse strains as old as 2 years. Human HSC engraftment of the murine liver was demonstrated by detection of high proliferative-potential colony-forming cells in clonal cultures, observation of CD38-CD34(++) and CD133(+)CD34(++) cells by flow cytometry, and hematopoietic reconstitution of secondary transplant recipients of chimeric liver cells. Additionally, chimeric mice with both hematopoietic and endothelial reconstitution were generated by intrasplenic injection of immunodeficient mice with liver specific expression of the urokinase-type plasminogen activator (uPA) transgene. In conclusion, the murine liver is shown to be a hematopoietic organ throughout adult life that can also support human hematopoiesis in severely immunodeficient strains. Further humanization of the murine liver can be achieved in mice harboring an uPA transgene, which support engraftment of non-hematopoietic cells types. Thus, offering a model system to study the interaction of diverse human liver cell types that regulate hematopoiesis and immune function in the liver.

Indexed as

HematopoiesisMorphogenesisAdultAnimalsBlood CellsCell TransplantationFemaleFetusHematopoietic Stem CellsHumansHybrid CellsLiverMast CellsMiceMice, TransgenicPregnancyUrokinase-Type Plasminogen Activator

Identifiers

PMID24819392
PMCPMC4018295
OpenAlexW2150019901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.